CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase II Prospective Randomized Trial of Donor T-memory Cells (CD45RA Depleted) Infusion for Prevention of Infections After Allogeneic TcRαβ/CD19-depleted Hematopoietic Stem Cell Transplantation
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02942173
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:16.549898+00:00
- Published At
- 2023-03-16T00:00:00+00:00
- Record Updated At
- 2023-03-16
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Leukemia", "Lymphoma", "Myelodysplastic Syndromes", "GvHD", "Opportunistic Infections", "Graft-versus-Host Disease"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-03-16"- protocolSection.identificationModule.nctId
"NCT02942173"- protocolSection.identificationModule.officialTitle
"A Phase II Prospective Randomized Trial of Donor T-memory Cells (CD45RA Depleted) Infusion for Prevention of Infections After Allogeneic TcR\u03b1\u03b2/CD19-depleted Hematopoietic Stem Cell Transplantation"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2", "PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.